| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18:46 | Roche breast cancer pill cleared by FDA | ||
| 17:46 | AI drugmaker Isomorphic restocks with $5B fundraise | ||
| 13:46 | Marrow sets out to challenge genetic medicines for severe blood diseases | ||
| Mo | Summit shares fall as FDA rejects closely watched PD-1/VEGF drug | ||
| Mo | J&J bets $2.2B on Ollin's vision loss drug | ||
| Mo | Lilly adds to buyout streak with $1.5B purchase of startup Calytrix | ||
| Mo | Big-name investors pour $100M into DNA therapeutics developer Seawolf | ||
| Mo | Completing the circle: the next evolution in sustainable pharmaceutical blister packaging | ||
| Mo | Your AI pilots aren't stalling because of the AI - they're stalling because of your environment | ||
| Mo | The infrastructure decisions that will enable tomorrow's biggest breakthroughs | ||
| Mo | One of Europe's leading VCs banks a €725M 'crossover' fund | ||
| Fr | Novo submits sickle cell drug; Flagship, Gates Foundation deepen ties | ||
| Fr | This week in charts: Brain drugs are back on venture capitalists' minds | ||
| Fr | Windward prices $175M IPO to advance China-licensed lung drugs | ||
| Do | Blackstone bets $1.5B on Pfizer's obesity drug | ||
| Do | Bristol Myers research chief to depart in 'evolution' of company's structure | ||
| Do | The FDA has over 1k open jobs - and the staffing shortage is hitting pharma | ||
| Mi | Drug price hikes in Germany could push US costs higher, study says | ||
| Mi | AstraZeneca buys vaccine startup; FDA issues GLP-1 safety warning | ||
| 10.11. | PepGen soars on promising early data for muscular dystrophy drug | ||
| 10.11. | Beam's base editing therapy for sickle cell hits goal in pivotal trial | ||
| 10.11. | London biotech Oyster harvests $60M for tau-targeting brain drugs | ||
| 09.11. | Bayer wins FDA nod for a new kind of blood thinner | ||
| 09.11. | Vir hepatitis D drug succeeds in first pivotal study | ||
| 09.11. | Argenx to buy peptide platform in potentially billion-dollar deal |